FRANKFURT, Jan 12 (Reuters) - Private equity firms Cinven [CINV.UL], Permira [PERM.UL] and Texas Pacific Group [TPG.UL] are interested in Merck KGaA (MRCG.DE: Quote, Profile , Research) generic drugs business, which it is considering selling, a source familiar with the matter said.
